Vanguard Group Inc Finch Therapeutics Group, Inc. Transaction History

Vanguard Group Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.36 - $56.4 $1,753 - $274,668	4,870 Added 0.48%	1,015,004 $487,000
Q2 2022 Aug 12, 2022	BUY	$1.91 - $5.11 $412,244 - $1.1 Million	215,835 Added 27.17%	1,010,134 $2.87 Million
Q1 2022 May 13, 2022	SELL	$5.02 - $10.47 $13,297 - $27,735	-2,649 Reduced 0.33%	794,299 $3.99 Million
Q4 2021 Feb 14, 2022	BUY	$8.95 - $16.88 $5.55 Million - $10.5 Million	620,019 Added 350.43%	796,948 $7.95 Million
Q3 2021 Nov 12, 2021	BUY	$12.2 - $16.75 $26,034 - $35,744	2,134 Added 1.22%	176,929 $2.3 Million
Q2 2021 Aug 13, 2021	BUY	$12.03 - $17.51 $2.1 Million - $3.06 Million	174,795 New	174,795 $2.46 Million

Ticker FNCH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,688,400
Market Cap $715M
Description
Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company's lead candidate is CP101, an orally administered microbiome capsule that is in Phase 3 clinical trial for the treatment of patients with recurrent Clostridioides diffi...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.